|
部份中文奈达铂/アクプラ静注用处方资料（仅供参考） アクプラ静注用10mg／アクプラ静注用50mg／アクプラ静注用100mgAQUPLA for Intravenous Injection 10mg（アクプラ静注用10mg）Brand name : AQUPLA for Intravenous Injection 10mg Active ingredient: Nedaplatin Dosage form: injection Print on wrapping: AQUPLA for Intravenous Injection 50mg（アクプラ静注用50mg） Brand name : AQUPLA for Intravenous Injection 50mg Active ingredient: Nedaplatin Dosage form: injection Print on wrapping: AQUPLA for Intravenous Injection 100mg（アクプラ静注用100mg） Brand name : AQUPLA for Intravenous Injection 100mg Active ingredient: Nedaplatin Dosage form: injection Print on wrapping: Effects of this medicine This medicine shows antitumor effects by suppressing tumor cell growth due to DNA synthesis inhibition. It is usually used for the treatment of head and neck cancer, small cell lung cancer, non-small cell lung cancer, esophagus cancer, bladder cancer, testicular tumor, ovarian cancer and uterine cervix cancer. Before using this medicine, be sure to tell your doctor and pharmacist •If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines. If you have myelosuppression or renal disorder. •If you are pregnant, possibly pregnant or breastfeeding. •If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.) Dosing schedule (How to take this medicine) •Your dosing schedule prescribed by your doctor is <<to be written by a healthcare professional>> •In general, for adults, this medicine is administered once daily by an intravenous drip infusion over 60 minutes or longer, and then it is discontinued for at least 4 weeks. This dosing schedule as 1 course is repeated. •After this medicine is used, a transfusion is successively administered by an intravenous drip infusion. •Consult with your doctor about your concrete schedule for use. Precautions while taking this medicine •If you are breastfeeding, discontinue breastfeeding while using this medicine. Possible adverse reactions to this medicine The most commonly reported adverse reactions include nausea, vomiting, loss of appetite and hair loss. If any of these symptoms occur, consult with your doctor or pharmacist. The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately. •hot flush, breathing difficulty, chill [shock, anaphylactoid symptoms] •fever, symptoms of anemia, bleeding tendency [myelosuppression] •swelling, malaise, decreased urine output [renal failure] •unable to hear voices and sounds, ear ringing [deafness, decreased hearing, tinnitus] •fever, dry cough, breathlessness [interstitial pneumonia] The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above. Shionogi & Co., Ltd.Injection Published: 2/2014 The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment. http://www.info.pmda.go.jp/go/pack/4291405F1025_1_10/ --------------------------------------------- 注：以下产品来同规格和不同价格，采购咨询为准！ --------------------------------------------- 产地国家：日本 原产地英文商品名: AQUPLA for Intravenous Injection(アクプラ静注用) 100MG/VIAL 原产地英文药品名: NEDAPLATIN 原产地英文化合物名称: cis-Diammineglycolatoplatinum 中文参考商品译名: AQUPLA(アクプラ静注用) 100毫克/瓶 中文参考药品译名: 奈达铂 生产厂家中文参考译名: 塩野義製薬 生产厂家英文名: shionogi
|
